Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

Semmelweis Egyetem ( Site 0507), Budapest

Szent Imre Egyetemi Oktatokorhaz ( Site 0502), Budapest

Chris OBrien Lifehouse ( Site 0051), Camperdown

Royal North Shore Hospital ( Site 0052), St Leonards

Lismore Base Hospital ( Site 0050), Lismore

Orange Health Services ( Site 0053), Orange

Alfred Health ( Site 0055), Melbourne

Debreceni Egyetem. ( Site 0506), Debrecen

Gold Coast University Hospital ( Site 0054), Southport

Szabolcs Szatmar Bereg Megyei Korhazak es Egyetemi Oktatokorhaz ( Site 0500), Nyíregyháza

Sunshine Coast University Private Hospital-Coastal Cancer Care ( Site 0056), Sunshine Coast

Haukeland sykehus ( Site 0851), Bergen

Szegedi Tudomanyegyetem ( Site 0504), Szeged

St. Olavs Hospital HF ( Site 0852), Trondheim

Pecsi Tudomanyegyetem AOK ( Site 0501), Pécs

Icahn School of Medicine at Mount Sinai ( Site 1575), New York

Universitaetsklinikum Berlin - Charite - Campus Mitte ( Site 0400), Berlin

Northwell Health/ RJ Zuckerberg Cancer Center-Medical Oncology ( Site 1565), Lake Success

Hopital Saint Joseph ( Site 0376), Marseille

Hopital La Timone ( Site 0353), Marseille

Centre Hospitalier Universitaire de Caen Normandie-DERMATOLOGY ( Site 0365), Caen

UPMC Hillman Cancer Center ( Site 1570), Pittsburgh

Onkologikoa - Instituto Oncologico de San Sebastian ( Site 1258), Doniostia - San Sebastian

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 0600), Milan

Istituto Europeo di Oncologia ( Site 0602), Milan

Universitaetsklinikum Hamburg-Eppendorf ( Site 0414), Hamburg

Elbe Kliniken Stade-Buxtehude, Klinikum Buxtehude-Dermatologisches Zentrum ( Site 0411), Buxtehude

Inova Schar Cancer Institute ( Site 1538), Fairfax

Limited Liability Company Ukrainian Center of Tomotherapy-Department of Chemotherapy ( Site 1451), Kropyvnytskyi

CHU Besancon - Hopital Jean Minjoz ( Site 0359), Besançon

West Virginia University ( Site 1569), Morgantown

Centre Hospitalier de Valence ( Site 0377), Valence

Cimab SA de CV ( Site 0708), Torreón

Centro de Investigación Clínica de Alta Especialidad ( Site 0715), Torreón

Hospital Universitario Ramon y Cajal ( Site 1251), Madrid

Hospital Universitario Carlos Haya ( Site 1255), Málaga

San Lucas Cardiologica del Sureste S.A de C.V. ( Site 0722), Tuxtla Gutiérrez

MUSC Hollings Cancer Center ( Site 1533), Charleston

C.H.U. de Nimes. Hopital Caremeau ( Site 0368), Nîmes

Medizinische Hochschule Hannover ( Site 0405), Hanover

Centro Estatal de Cancerologia de Chihuahua ( Site 0703), Chihuahua City

Institut Claudius Regaud IUCT Oncopole ( Site 0354), Toulouse

UF Health ( Site 1511), Gainesville

CHU de Bordeaux- Hopital Saint Andre ( Site 0370), Bordeaux

University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 1544), Miami

Boca Raton Regional Hospital ( Site 1551), Boca Raton

CHU Montpellier. ( Site 0367), Montpellier

Universitatsklinikum Giessen und Marburg GmbH ( Site 0413), Marburg

University of South Alabama, Mitchell Cancer Institute ( Site 1562), Mobile

Vanderbilt Ingram Cancer Center ( Site 1543), Nashville

West Cancer Center - East Campus ( Site 1535), Germantown

Hospital Universitario Marques de Valdecilla ( Site 1256), Santander

Sumy regional clinical oncological dispensary-Oncothoracic department ( Site 1452), Sumy

University of Kentucky School of Medicine & Hospitals ( Site 1542), Lexington

Cleveland Clinic ( Site 1541), Cleveland

Onco-Hematologia de Occidente ( Site 0716), Guadalajara

Hospital de Especialidades Centro Medico de Occidente ( Site 0704), Guadalajara

Consultorios de Medicina Especializada del Sector Privado ( Site 0701), Guadalajara

Universitaetsklinikum Essen ( Site 0403), Essen

Indiana University Melvin and Bren Simon Cancer Center ( Site 1515), Indianapolis

University of Iowa Hospital and Clinics ( Site 1514), Iowa City

Azienda Ospedaliero Universitaria Pisana ( Site 0603), Pisa

CHRU de Lille - Hopital Claude Huriez ( Site 0355), Lille

Institute of General and Emergency Surgery named after V.T. Zaitsev NAMS of Ukraine ( Site 1450), Kharkiv

CHU Estaing ( Site 0360), Clermont-Ferrand

Fundación Cardiovascular de Colombia ( Site 0207), Piedecuesta

CH Lyon Sud Hospices Civils de Lyon ( Site 0350), Pierre-Bénite

Instituto Tumori Giovanni Paolo II ( Site 0604), Bari

Universitaetsklinikum Tuebingen ( Site 0409), Tübingen

Centre Hospitalier Annecy Genevois ( Site 0361), Pringy

"Communal Non-Commercial Enterprise Prykarpatski Clinical On-Department for daily treated patient (", Ivano-Frankivsk

The University of Texas-MD Anderson Cancer Center ( Site 1536), Houston

University of Colorado Cancer Center ( Site 1506), Aurora

Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 0601), Napoli

Huntsman Cancer Institute ( Site 1537), Salt Lake City

CHU Poitiers ( Site 0375), Poitiers

UCLA Hematology/Oncology - Westwood (Building 100) ( Site 1568), Los Angeles

Klinikum Nürnberg Nord ( Site 0415), Nuremberg

City of Hope Medical Center ( Site 1505), Duarte

FAICIC Clinical Research ( Site 0700), Veracruz

Hopital Avicenne ( Site 0358), Bobigny

Stanford University Medical Center ( Site 1503), Stanford

Institut Gustave Roussy ( Site 0352), Villejuif

University of California Davis Comprehensive Cancer Center ( Site 1560), Sacramento

Centro de atencion e investigacion clinica en oncologia ( Site 0706), Mérida

Providence Portland Medical Center ( Site 1530), Portland

Sociedad de Cirugía de Bogotá - Hospital de San Jose ( Site 0201), Bogotá

Instituto Nacional de Cancerologia E.S.E ( Site 0204), Bogotá

N.N. Blokhin NMRCO ( Site 1153), Moscow

FSCC FMBA of Russia ( Site 1163), Moscow

First Moscow State Medical University n.a. I.M.Sechenov ( Site 1164), Moscow

Hadassah Medical-Oncology department ( Site 1173), Moscow

Yaroslavl Regional SBIH Clinical Oncology Hospital ( Site 1152), Yaroslavl

Railway Hospital of OJSC ( Site 1161), Saint Petersburg

S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1101), Craiova

Oncomedica S.A. ( Site 0205), Montería

A. Tsyb Medical Radiological Research Center - branch of the National Medical Research Radiological, Obninsk

S C Oncocenter Oncologie Medicala S R L ( Site 1106), Timișoara

Policlinica Oncomed SRL ( Site 1105), Timișoara

Oncological Dispensary #2 of Ministry of Health of Krasnodar region ( Site 1159), Sochi

Cardiomed SRL Cluj-Napoca ( Site 1104), Cluj-Napoca

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 1113), Cluj-Napoca

Spitalul Universitar CF Cluj-Napoca ( Site 1103), Cluj-Napoca

S C Pelican Impex SRL ( Site 1108), Oradea

Udmurtia Republic Regional Clinical Oncology Dispensary ( Site 1158), Izhevsk

GBUZ Republican Clinical Oncological Dispensary-Antitumor drug therapy department ( Site 1171), Ufa

Nizhniy Novgorod regional clinical oncological dispensary ( Site 1169), Nizhny Novgorod

Altay Regional Oncology Dispensary ( Site 1168), WBarnaularsaw

Oncologos del Occidente S.A. ( Site 0206), Pereira

Fundación Valle del Lili ( Site 0202), Santiago de Cali

Bradford Hill Norte ( Site 1652), Antofagasta

Rambam Health Care Campus-Oncology Division ( Site 0552), Haifa

Meir Medical Center ( Site 0556), Kfar Saba

James Lind Centro de Investigación del Cáncer ( Site 1653), Temuco

Rabin Medical Center ( Site 0550), Petah Tikva

Chaim Sheba Medical Center ( Site 0551), Ramat Gan

Sourasky Medical Center ( Site 0554), Tel Aviv

Enroll SpA ( Site 1654), Santiago

Soroka University Medical Center ( Site 0555), Beersheba

Bradfordhill ( Site 1651), Santiago

Haddassah Medical Organization - Ein Kerem ( Site 0553), Jerusalem

ONCOSITE - Centro de Pesquisa Clinica em Oncologia ( Site 0100), Ijuí

UCSD Moores Cancer Center ( Site 1561), La Jolla

Smilow Cancer Center at Yale-New Haven ( Site 1507), New Haven

Winship Cancer Institute of Emory University ( Site 1512), Atlanta

Massachusetts General Hospital ( Site 1518), Boston

Dana Farber Cancer Center ( Site 1519), Boston

John Theurer Cancer Center at Hackensack University Medical Center ( Site 1526), Hackensack

Centro de Investigaciones Metabólicas (CINME)-Oncology ( Site 0028), Ciudad Autónoma de Buenos Aires

Centro Medico Privado CEMAIC ( Site 0024), Capital

Fundacion Estudios Clinicos-Oncology ( Site 0026), Rosario

Centro Oncológico de Rosario ( Site 0003), Rosario

Hospital Italiano- Sociedad Italiana de Beneficencia en Buenos Aires ( Site 0009), Buenos Aires

CEMIC ( Site 0012), Buenos Aires

Fundacion CIDEA ( Site 0001), CABA

Centro Oncologico Riojano Integral ( Site 0002), La Rioja

Centro Oncologico Norte ( Site 0023), Santiago del Estero

Oncocentro Ceara ( Site 0108), Fortaleza

Hospital Erasto Gaertner ( Site 0101), Curitiba

Hospital Tacchini ( Site 0111), Bento Gonçalves

Hospital Bruno Born ( Site 0107), Lajeado

Hospital Sao Vicente de Paulo ( Site 0105), Passo Fundo

Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA-Pesquisa Clinica HC II ( Site 0103), Rio de Janeiro

A. C. Camargo Cancer Center ( Site 0116), São Paulo

Tom Baker Cancer Center ( Site 0161), Calgary

Cross Cancer Institute ( Site 0159), Edmonton

Juravinski Cancer Center ( Site 0151), Hamilton

The Ottawa Hospital Cancer Centre ( Site 0154), Ottawa

CIUSSS de l'Est-de-l'Île-de-Montréal ( Site 0163), Montreal

McGill University Health Centre ( Site 0162), Montreal

Hopital ARCHET 2 ( Site 0356), Nice

Andreas Syggros Hospital ( Site 0450), Athens

Attikon University General Hospital of Athens ( Site 0454), Chaïdári

Metropolitan Hospital ( Site 0453), Neo Faliro

Papageorgiou General Hospital ( Site 0451), Thessaloniki

European Interbalkan Medical Center ( Site 0455), Thessaloniki

St. James s Hospital ( Site 1601), Dublin

New Zealand Clinical Research (Auckland) ( Site 0800), Auckland

Oslo Universitetssykehus Radiumhospitalet ( Site 0850), Oslo

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Oddzial w Krakowie ( Site 0959), Krakow

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 0951), Warsaw

Uniwersyteckie Centrum Kliniczne-Klinika Chirurgii Onkologicznej, Transplantacyjnej i Ogólnej ( Site, Gdansk

Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 0958), Gliwice

Hospital Particular do Algarve ( Site 1005), Faro

Instituto Portugues de Oncologia de Lisboa ( Site 1003), Lisbon

Hospital CUF - Tejo ( Site 1004), Lisbon

CHLN Hospital Santa Maria ( Site 1001), Lisbon

Inst. Portugues de Oncologia de Porto Francisco Gentil EPE ( Site 1000), Porto

Hifu Terramed Conformal SRL ( Site 1111), Bucharest

S.C.Focus Lab Plus S.R.L ( Site 1107), Bucharest

Spitalul de Psihiatrie Titan Dr. Constantin Gorgos ( Site 1112), Bucharest

Hospital Duran i Reynals ( Site 1254), Hospitalet Del Llobregat

Hospital Clinic i Provincial Barcelona ( Site 1253), Barcelona

Hospital General Universitari Vall d Hebron ( Site 1252), Barcelona

Universal Clinic Oberig-Oncology Center ( Site 1461), Kyiv

Royal Cornwall Hospitals NHS Trust ( Site 1402), Truro

University College Hospital London ( Site 1400), London

Guy s & St Thomas NHS Foundation Trust ( Site 1407), London

The Royal Marsden Hospital-Institute of Cancer Research ( Site 1406), London

Royal Marsden NHS Foundation Trust ( Site 1408), Sutton

Churchill Hospital ( Site 1404), Oxford